ClinicalTrials.gg
CompletedNCT03499613Updated Jan 11, 2022

Spinal Kinematics in Chronic Low Back Pain

An observational study in Chronic Low Back Pain, sponsored by Haute Ecole de Santé Vaud. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-01-11.

Sponsored by Haute Ecole de Santé Vaud · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
71
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Chronic low back pain (CLBP) is one of the most frequent causes for limitations in daily, leisure and work-related activities. Although alterations in spinal motor behavior were consistently reported in CLBP patients, it remains unclear how improvements in spinal motor behavior through rehabilitation treatment affect pain and disability. Psychological factors, such as pain-related fear, were suggested as a possible main cause of spinal motor behavior in CLBP and better understanding their relationships with kinematic and muscle activity alterations is required to enhance care, particularly physiotherapy. Therefore, this study will test CLBP patients before and after a 3 week rehabilitation program to test the hypotheses that: 1) improvements in spinal motor behavior (kinematics and trunk muscle activity) are associated with decreased pain and disability; 2) decrease in pain-related fear is associated with spinal motor behavior improvements.

Read the detailed description

The research project is a prospective observational cohort study. CLBP patients participating to a 3 weeks' multimodal rehabilitation program will be tested in the motion analysis laboratory before (T1) and after (T2) the program. This program is an intensive 3-weeks multidisciplinary rehabilitation program. Patients come daily for individual and group treatments, with a total of 100 hours of intervention during 3 weeks. The program includes physiotherapy treatments, occupational therapy, psychologists encounters and education session. The programs encompasses a multidimensional view of chronic low back pain. Therefore, this setting is a unique opportunity to improve our understanding of the role of motor behavior alterations in CLBP because it will allow connecting changes in spinal kinematics and muscle activity with changes in pain, disability and pain-related fear.

This project has two aims in relation to motor behavior in patients with CLBP:

The first aim is to analyse the relationship between changes in spinal kinematics and changes in pain and disability during and after a multimodal rehabilitation program. First, changes in spinal kinematics and muscle activity between T1 and T2 will be calculated. The relationship between these changes and changes in pain and disability during the program will be tested. Pain and disability will be also measured at 3 months (T3) and one year (T4) after the program, which will allow to further analyze the relationship between spinal motor behavior and pain and disability.

The second aim concerns the role of pain-related fear, and its decrease, in spinal motor behavior alterations. Consequently, the second aim is to analyse if changes in pain-related fear are associated with changes in spinal kinematics during a multimodal rehabilitation program.

02

Conditions studied

  • Chronic Low Back Pain

Browse trials for

Keywords

  • Movement analysis
  • Spinal kinematics
  • Muscle activity
  • Pain-related fear
  • Rehabilitation
  • Spine
03

In context

Low Back Pain

2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

This study's enrollment of 71 is below the median of 100 across 481 observational studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Haute Ecole de Santé Vaud is the lead sponsor of 17 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with chronic low back pain for more than three months participating to a 3 weeks' multidisciplinary rehabilitation program

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • non-specific low back pain (pain from lower ribs to gluteal folds) for more than 3 months
  • sufficient French level to understand the instructions for the tests, the information sheet, the consent form and the questionnaires
  • both male and female adults will be included
  • age more than 18 years old.

Exclusion criteria

Exclusion Criteria:

  • pregnancy
  • skin allergy to tape
  • (BMI) above 32
  • any sign of specific low back pain such as the presence of infection, rheumatologic or neurological diseases, spinal fractures, any known important spinal deformities, previous back surgery that limits spinal mobility, tumours
  • high level of pain at the time of experiment that prevents repeated movements (severity and irritability)
  • other concomitant pain or condition that could compromise the evaluation of spinal kinematics.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
71 participants (actual)
Patient registry
No

Groups and cohorts

  • Chronic low back pain

    Patients with chronic low back pain participating to a 3 weeks Multidisciplinary rehabilitation program

    Other: Multidisciplinary rehabilitation program

Interventions

  • OtherMultidisciplinary rehabilitation program

    The multimodal rehabilitation program (MRP) based at the University Hospital is an intensive 3-weeks multidisciplinary rehabilitation program. Patients come daily for individual and group treatments, with a total of 100 hours of intervention during 3 weeks. The MRP includes physiotherapy treatments, aiming at improving cardio-vascular endurance, long-term physical activity adherence, proprioception, mobility and strength. Additionally, occupational therapy is mainly focussed on reassuring patients that spinal movements are safe. Finally, psychologists are involved in the MRP to discuss the meaning of LBP, the psychological implications and the patient's resources.

06

What researchers measure

Primary outcomes

  1. Spinal kinematics

    Range of movement and angular velocity at the lower lumbar, upper lumbar, lower thoracic and upper thoracic joints

    Time frame: Change between baseline and week 4

  2. Trunk muscle activity

    Surface electromyography of paraspinal and abdominal muscles

    Time frame: Change between baseline and week 4

  3. Pain intensity

    Pain intensity will be quantified by the 11-point Numeric Pain Rating Scale. The scale range from 0 (no pain at all) to 10 (worst pain).

    Time frame: Change between baseline and week 4

  4. Disability

    Disability will be quantified by the Patient Specific Functional Scale. The scale assessed three relevant activities for the patient and scores each activity between 0 (impossible to realize the activity) to 10 (capable of doing the activity normally).

    Time frame: Change between baseline and week 4

  5. Kinesiophobia

    Tampa Scale of Kinesiophobia. The total score is between 17 (no kinesiophobia) to 68 (high level of kinesiophobia).

    Time frame: Change between baseline and week 4

  6. Pain-related fear

    Photograph Series of Daily Activities. The score is from 0 (no pain-related fear) to 100 (high levels of pain related fear)

    Time frame: Change between baseline and week 4

  7. Fear

    Fear scale measured before each movement or activity. Score between 0 (no fear) and 10 (high levels of fear).

    Time frame: Change between baseline and week 4

  8. Pain expectation

    Pain expectation scale before each movement or activity. Score between 0 (no pain expected) and 10 (high levels of pain expected).

    Time frame: Change between baseline and week 4

Secondary outcomes

  1. Disability (ODI)

    Oswestry Disability Questionnaire. Score between 0 (no disability) and 100.

    Time frame: Baseline (Day 0), week 4, Month 3, Month 12

  2. Disability

    Disability will be quantified by the Patient Specific Functional Scale. The scale assessed three relevant activities for the patient and scores each activity between 0 (impossible to realize the activity) to 10 (capable of doing the activity normally).

    Time frame: Month 3, Month 12

  3. Pain intensity

    Pain intensity will be quantified by the 11-point Numeric Pain Rating Scale. The scale range from 0 (no pain at all) to 10 (worst pain).

    Time frame: Month 3, Month 12

  4. Catastrophizing

    Pain Catastrophizing Scale. Score between 0 and 52 (high levels of catastrophizing).

    Time frame: Baseline (Day 0), week 4, Month 3, Month 12

  5. Back Pain Attitudes

    Back Pain Attitudes Questionnaires. Score between 34 (positive attitudes and beliefs) and 170 (negative attitudes and beliefs)

    Time frame: Baseline (Day 0), week 4, Month 3, Month 12

  6. Kinesiophobia

    Tampa Scale of Kinesiophobia. The total score is between 17 (no kinesiophobia) to 68 (high level of kinesiophobia).

    Time frame: Month 3, Month 12

  7. Level of Bothersomeness

    Bothersomeness mesaured with a scale with one question scored from 0 to 4 (Dunn et al, Spine, 2005).

    Time frame: Baseline (Day 0), week 4, Month 3, Month 12

  8. Level of Worry about back pain

    Worry numeric scale. Worry about current back pain is scored from 0 (no worry) to 10 (extremely worried).

    Time frame: Baseline (Day 0), week 4, Month 3, Month 12

  9. Work ability

    Work ability. Is back pain limiting the ability to work normally (answer: Yes or No)?

    Time frame: Baseline (Day 0), Month 3, Month 12

  10. Patient Global Impression of Change

    This measure is a single-item rating by participants of their improvement with treatment on a 7-point scale that ranges from 'very much improved' (3 points) to 'very much worse' (-3 points) with 'no change' as the mid-point (0 points). The patient will answer this question: "With respect to your low back pain how would you describe yourself now, compared to before the start of the rehabilitation program you did at the University Hospital?"

    Time frame: Month 3, Month 12

Other outcomes

  1. Fear of moving

    Is there any movement or activity that you don't do or do differently because they are harmful or dangerous for your back ?

    Time frame: Baseline (Day 0)

  2. Localization of pain

    Body chart with localization of pain

    Time frame: Baseline (Day 0)

  3. Aggravating factors

    Which movements or activity increase pain ?

    Time frame: Baseline (Day 0)

  4. Medication

    Number of medication for low back pain

    Time frame: Baseline (Day 0), week 4, Month 3, Month 12

07

Study locations

1 site
  • University of Lausanne Hospitals
    Lausanne, Vaud 1011, Switzerland
08

References and documents

Publications

  • Christe G, Redhead L, Legrand T, Jolles BM, Favre J. Multi-segment analysis of spinal kinematics during sit-to-stand in patients with chronic low back pain. J Biomech. 2016 Jul 5;49(10):2060-2067. doi: 10.1016/j.jbiomech.2016.05.015. Epub 2016 May 20. PubMed 27262182 ↗
  • Christe G, Kade F, Jolles BM, Favre J. Chronic low back pain patients walk with locally altered spinal kinematics. J Biomech. 2017 Jul 26;60:211-218. doi: 10.1016/j.jbiomech.2017.06.042. Epub 2017 Jul 5. Erratum In: J Biomech. 2019 Jan 23;83:329. doi: 10.1016/j.jbiomech.2018.12.033. PubMed 28716466 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 11, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03499613
Lead sponsor
Haute Ecole de Santé Vaud
Collaborators
University of Lausanne Hospitals, University of Lausanne
Responsible party
Sponsor
First posted
Apr 17, 2018
Start date
Apr 13, 2018
Primary completion
Oct 30, 2020
Completion
Oct 30, 2021
Last update
Jan 11, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion